GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
23.99
+1.61 (7.19%)
At close: May 29, 2026, 4:00 PM EDT
23.55
-0.44 (-1.83%)
After-hours: May 29, 2026, 7:42 PM EDT
GH Research Market Cap
GH Research has a market cap or net worth of $1.65 billion as of May 29, 2026. Its market cap has increased by 165.88% in one year.
Market Cap
1.65B
Enterprise Value
1.38B
1-Year Change
165.88%
Ranking
Category
Stock Price
$23.99
Market Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has increased from $808.33M to $1.65B, an increase of 103.62%. That is a compound annual growth rate of 15.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 1.65B | 108.93% |
| Dec 31, 2025 | 787.77M | 116.30% |
| Dec 31, 2024 | 364.20M | 20.71% |
| Dec 29, 2023 | 301.72M | -40.33% |
| Dec 30, 2022 | 505.64M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
| Jun 25, 2021 | 808.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vir Biotechnology | 1.61B |
| Precigen | 1.61B |
| uniQure | 1.57B |
| Ardelyx | 1.54B |
| Biohaven | 1.54B |
| Immatics | 1.54B |
| Damora Therapeutics | 1.53B |
| Inhibrx Biosciences | 1.53B |